Posted by admin on May 14th, 2022
Retractable Technologies (NYSE:RVP – Get Rating) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a report issued on Thursday.
Shares of RVP stock opened at $4.00 on Thursday. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.96 and a quick ratio of 2.38. The stock has a market capitalization of $132.49 million, a PE ratio of 2.45 and a beta of 1.92. Retractable Technologies has a one year low of $3.28 and a one year high of $13.91.
Retractable Technologies Company Profile (Get Rating)
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
StockNews.com Upgrades American Equity Investment Life (NYSE:AEL) to “Buy”
Universal Display Co. (NASDAQ:OLED) Receives Average Recommendation of “Buy” from Analysts